Cintas Corp (CTAS) 118.84 $CTAS Cintas (CTAS) Crosses

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cintas Corp (CTAS) 118.84 $CTAS

Cintas (CTAS) Crosses Pivot Point Resistance at $117.97
Comtex SmarTrend(R) - Thu Sep 01, 8:49AM CDT
Shares of Cintas (NASDAQ:CTAS) have bullishly opened above the pivot of $117.23 today and have reached the first resistance level of $117.97. Should the shares continue to rise, the resistance pivots of $118.42 and $119.61 will be of interest.
CTAS: 118.84 (+1.14)

Cintas Shares Up 33.7% Since SmarTrend's Buy Recommendation (CTAS)
Comtex SmarTrend(R) - Tue Aug 30, 1:18PM CDT
SmarTrend identified an Uptrend for Cintas (NASDAQ:CTAS) on March 4th, 2016 at $87.01. In approximately 6 months, Cintas has returned 33.66% as of today's recent price of $116.30.
CTAS: 118.84 (+1.14)

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of G&K Services, Inc. And Encourages Shareholders To Contact The Firm For Additional Information
BusinessWire - Thu Aug 25, 9:00PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of G&K Services, Inc. (NASDAQ: GK) ("G&K" or the "Company" relating to the proposed buyout of G&K by Cintas Corporation.
CTAS: 118.84 (+1.14), GK: 97.44 (+0.20)

Cintas Set to Possibly Pullback After Yesterday's Rally of 1.67%
Comtex SmarTrend(R) - Thu Aug 25, 1:05PM CDT
Cintas (NASDAQ:CTAS) traded in a range yesterday that spanned from a low of $114.42 to a high of $116.67. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $114.75 on volume of 341,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CTAS: 118.84 (+1.14)

After Yesterday's Rally of 1.67% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Aug 25, 1:04PM CDT
Cintas (NASDAQ:CTAS) traded in a range yesterday that spanned from a low of $114.42 to a high of $116.67. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $114.75 on volume of 341,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CTAS: 118.84 (+1.14)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of G&K Services Inc. to Cintas Corp. for $97.50 Per Share is Fair to Shareholders -- GK
PR Newswire - Tue Aug 23, 2:34PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
CTAS: 118.84 (+1.14), GK: 97.44 (+0.20)

31.1% Return Seen to Date on SmarTrend Cintas Call (CTAS)
Comtex SmarTrend(R) - Tue Aug 23, 12:58AM CDT
SmarTrend identified an Uptrend for Cintas (NASDAQ:CTAS) on March 4th, 2016 at $87.01. In approximately 6 months, Cintas has returned 31.05% as of today's recent price of $114.03.
CTAS: 118.84 (+1.14)

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of G&K Services, Inc. And Encourages Investors To Contact The Firm For Additional Information
BusinessWire - Mon Aug 22, 4:28PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of G&K Services, Inc. (NASDAQ: GK) ("G&K" or the "Company" relating to the proposed buyout of G&K by Cintas Corporation.
CTAS: 118.84 (+1.14), GK: 97.44 (+0.20)

INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation into Whether the Sale of G&K Services Inc. to Cintas Corp. for $97.50 Per Share is Fair to Shareholders
BusinessWire - Thu Aug 18, 2:30PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
CTAS: 118.84 (+1.14), GK: 97.44 (+0.20)

G&K SERVICES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of G&K Services
PR Newswire - Thu Aug 18, 12:39PM CDT
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF" are investigating the proposed sale of G&K Services, Inc. ("G&K" or the "Company" (NASDAQ: GK) to Cintas Corporation (NASDAQ: CTAS). Under the terms of the proposed transaction, shareholders of G&K will receive only $97.50 in cash for each share of G&K that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
CTAS: 118.84 (+1.14), GK: 97.44 (+0.20)

G&K SERVICES, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Cintas Corporation
BusinessWire - Thu Aug 18, 11:36AM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of G&K Services, Inc. ("G&K" (NASDAQ: GK) concerning the sale to Cintas Corporation. Under the terms of the agreement, G&K shareholders will only receive $97.50 for each share owned, which is virtually no premium over the 52-week high and lower than at least one analyst's estimated value of $98.00 per share.
CTAS: 118.84 (+1.14), GK: 97.44 (+0.20)

Ryan & Maniskas, LLP Announces Investigation of G&K Services Inc.
PR Newswire - Thu Aug 18, 9:45AM CDT
Ryan & Maniskas, LLP is investigating potential claims against the board of directors of G&K Services Inc. ("G&K" or the "Company" (NASDAQ: GK) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to Cintas Corporation in a transaction valued at approximately $2.2 billion.
CTAS: 118.84 (+1.14), GK: 97.44 (+0.20)

Cintas Corporation Ranked 4th in the Nation for Certified Occupational Safety and Health Sites
BusinessWire - Thu Aug 18, 8:23AM CDT
Cintas Corporation (NASDAQ: CTAS) today announced that its locations in Landover, Frederick and Waldorf, MD received Voluntary Protection Program (VPP) Star certification from the Maryland Occupational Safety and Health Administration (MOSH). VPP Star is the highest recognition for the practice of and commitment to exemplary occupational safety and health.
CTAS: 118.84 (+1.14)

InvestorsObserver releases covered-call reports for NVIDIA, Dicks Sporting Goods, Cintas, Priceline and Merck & Company Incorporated
PR Newswire - Wed Aug 17, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for CTAS, DKS, MRK, NVDA, and PCLN.
CTAS: 118.84 (+1.14), DKS: 59.03 (+0.24), MRK: 62.98 (+0.08), PCLN: 1,422.85 (+4.26), NVDA: 62.53 (-0.62)

G&K (GK) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of G&K Services, Inc.; Are Shareholders Getting a Fair Price?
PR Newswire - Wed Aug 17, 7:38AM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of G&K Services, Inc. (NASDAQ: GK) breached their fiduciary duties in connection with the proposed sale of the Company to Cintas Corporation (NASDAQ: CTAS). G&K provides branded uniform and facility services programs.
CTAS: 118.84 (+1.14), GK: 97.44 (+0.20)

Cintas (CTAS) to Acquire G&K Services to Foster Growth
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 6:49AM CDT
Cintas Corporation (CTAS) recently inked a definitive agreement to acquire rival G&K Services Inc. (GK) to fuel its growth momentum.
CBZ: 11.23 (unch), CTAS: 118.84 (+1.14), GK: 97.44 (+0.20), CRAI: 26.73 (+0.21)

SmarTrend Watching for Potential Pullback in Shares of Cintas After 6.96% Gain
Comtex SmarTrend(R) - Tue Aug 16, 12:51PM CDT
Cintas (NASDAQ:CTAS) traded in a range yesterday that spanned from a low of $114.21 to a high of $117.65. Yesterday, the shares gained 7.0%, which took the trading range above the 3-day high of $107.93 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CTAS: 118.84 (+1.14)

Cintas Rises 6.96% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Aug 16, 12:50PM CDT
Cintas (NASDAQ:CTAS) traded in a range yesterday that spanned from a low of $114.21 to a high of $117.65. Yesterday, the shares gained 7.0%, which took the trading range above the 3-day high of $107.93 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CTAS: 118.84 (+1.14)

G&K Services Announces Agreement to Be Acquired by Cintas in $2.2 Billion All-Cash Transaction; Reports Record Fiscal 2016 Fourth Quarter Results
BusinessWire - Tue Aug 16, 7:35AM CDT
--Purchase Price Represents Nearly 20 Percent Premium to the Stock's All-Time Closing High and 14.0x LTM EBITDA Multiple(1)
CTAS: 118.84 (+1.14), GK: 97.44 (+0.20)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 36

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 102

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 353

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 24

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 395

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 8

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 28

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading

Top 5 Most Recently Viewed Articles

DENTSPLY SIRONA Inc. Faces Class Action for Alleged Fraud

Updated Category News Views 255

DENTSPLY SIRONA Inc. Faces Legal Challenges The law firm Kessler Topaz Meltzer & Check, LLP has informed investors about a securities class action lawsuit filed against DENTSPLY SIRONA Inc. (NASDAQ: XRAY). This lawsuit could have significant implications for investors who acquired DENTSPLY common stock between certain periods. Important Details for Investors Investors who...

Continue Reading
Revolutionizing Comfort in Urine Collection Systems

Updated Category News Views 166

Innovative External Urine Collection System An inventive individual from Stanwood has developed a groundbreaking external urine collection system aimed at improving comfort and health outcomes. The new system, known as the PART TIME CARETAKER, is designed to replace traditional indwelling urinary catheters. The inventor emphasizes the importance of comfort and reducing...

Continue Reading
Exploring Investors' Recent Movements in Apple Options

Updated Category News Views 132

Understanding Recent Investment Trends in Apple Options Recent activity in the options market shows that wealthy investors are betting on a positive outlook for Apple (NASDAQ:AAPL). This is notable for retail traders who closely monitor market dynamics. Insights from Option Trading Data Publicly available options trading history reveals an intriguing landscape of...

Continue Reading
Fat of the Land Expands to Irvine, Boosts Dining Scene

Updated Category News Views 30

Irvine Welcomes New Dining Destination And there it is, a fresh dining oasis gearing up to turn some heads out in Irvine. The Centerview is about to get even spicier with Fat of the Land, a celebrated tapas joint from Robert Paetz, making its way from Santa Ana to redefine what it means to dine in style. The Appeal of a ‘Third Space’ We’re not just talking about...

Continue Reading
Understanding Kaixin Holdings' Share Consolidation Strategy

Updated Category News Views 122

Key Announcement from Kaixin Holdings Kaixin Holdings, a prominent entity in the new energy vehicle sector, recently shared an important update regarding its financial structure. The company announced a share consolidation, which will take place at a ratio of 1-for-60. This consolidation is aimed at refining its capital structure and enhancing shareholder value. Details...

Continue Reading